Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients. [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial update indicates completion of Phase 2 and Phase 3 studies evaluating MIN-102 for efficacy and safety in male patients with Adrenoleukodystro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenoleukodystrophy
• Adrenomyeloneuropathy

Drugs mentioned

• MIN-102

Snippet

Sponsor: Minoryx Therapeutics, S.L. | Conditions: Adrenoleukodystrophy | Phase 2, Phase 3 | Status: COMPLETED